Unichem recalls 368 bottles of Lamotrigine tablets in US

06 Oct 2016 Evaluate

Unichem Laboratories is recalling 368 bottles of Lamotrigine tablets, used for treating epilepsy and bipolar disorder, in the US due to incorrect imprint debossed on the tablets. The company has initiated the recall on August 19 this year.

The recall has been initiated by the company’s US arm Unichem Pharmaceuticals Inc covering 368 bottles of Lamotrigine tablets USP in strength of 150 mg. The tablets have been manufactured at the company’s Goa facility. A single bottle contains 500 tablets of the medicine.

The recall is a ‘Class III recall’ and as per the US Food and Drug Administration (USFDA), a Class III recall is initiated in a situation, in which use of or exposure to a violative product is not likely to cause adverse health consequences.

Unichem Laboratories is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world. In India, the company is a leader in niche therapy areas of cardiology, neurology, orthopedics and anti-infectives.



Unichem Lab Share Price

702.00 2.00 (0.29%)
10-Jan-2025 14:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1788.00
Dr. Reddys Lab 1358.45
Cipla 1474.15
Lupin 2202.55
Zydus Lifesciences 1007.00
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.